DE3766984D1 - Stabile injizierbare arzneiformulierung des 1,4-dihydroxy-5,8-bis((2-(hydroxyaethylamino)-aethyl)amino)anthrachinondihydrochlorids. - Google Patents

Stabile injizierbare arzneiformulierung des 1,4-dihydroxy-5,8-bis((2-(hydroxyaethylamino)-aethyl)amino)anthrachinondihydrochlorids.

Info

Publication number
DE3766984D1
DE3766984D1 DE8787102448T DE3766984T DE3766984D1 DE 3766984 D1 DE3766984 D1 DE 3766984D1 DE 8787102448 T DE8787102448 T DE 8787102448T DE 3766984 T DE3766984 T DE 3766984T DE 3766984 D1 DE3766984 D1 DE 3766984D1
Authority
DE
Germany
Prior art keywords
hydroxyaethylamino
anthrachinone
aethyl
dihydrochloride
dihydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787102448T
Other languages
English (en)
Inventor
Pradeep V Niphadkar
Narendra R Desai
Paul N Jones
Kieran G Mooney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE3766984D1 publication Critical patent/DE3766984D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE8787102448T 1986-03-07 1987-02-20 Stabile injizierbare arzneiformulierung des 1,4-dihydroxy-5,8-bis((2-(hydroxyaethylamino)-aethyl)amino)anthrachinondihydrochlorids. Expired - Lifetime DE3766984D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83724386A 1986-03-07 1986-03-07

Publications (1)

Publication Number Publication Date
DE3766984D1 true DE3766984D1 (de) 1991-02-07

Family

ID=25273922

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787102448T Expired - Lifetime DE3766984D1 (de) 1986-03-07 1987-02-20 Stabile injizierbare arzneiformulierung des 1,4-dihydroxy-5,8-bis((2-(hydroxyaethylamino)-aethyl)amino)anthrachinondihydrochlorids.

Country Status (21)

Country Link
EP (1) EP0236822B1 (de)
JP (1) JPH0717500B2 (de)
KR (1) KR900002030B1 (de)
AT (1) ATE59290T1 (de)
AU (1) AU593330B2 (de)
CA (1) CA1283607C (de)
DE (1) DE3766984D1 (de)
DK (1) DK166754B1 (de)
ES (1) ES2033247T3 (de)
FI (1) FI84977C (de)
GR (1) GR3001503T3 (de)
HK (1) HK63991A (de)
HU (1) HU199286B (de)
IE (1) IE60025B1 (de)
IL (1) IL81681A (de)
NO (1) NO173635C (de)
NZ (1) NZ219454A (de)
PH (1) PH22808A (de)
PT (1) PT84398B (de)
SG (1) SG45292G (de)
ZA (1) ZA871652B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE188870T1 (de) * 1994-10-04 2000-02-15 Lohmann Rudolf Lomapharm Lösungen von anthrachinonen zur parenteralen applikation
DE19818802A1 (de) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stabile Mitoxantron-Lösungen
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
JP5538568B2 (ja) 2010-12-09 2014-07-02 丸石製薬株式会社 アセトアミノフェンの安定化剤
CN114601791B (zh) * 2020-12-08 2023-09-19 成都倍特药业股份有限公司 一种盐酸米托蒽醌液体制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230143A (en) * 1965-05-14 1966-01-18 Merck & Co Inc Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
US4328213A (en) * 1979-11-28 1982-05-04 Schering Corporation Stable injectable labetalol formulation
DE3574932D1 (de) * 1984-02-27 1990-02-01 American Cyanamid Co Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva.

Also Published As

Publication number Publication date
EP0236822A3 (en) 1989-01-11
EP0236822B1 (de) 1990-12-27
FI870994A (fi) 1987-09-08
KR870008581A (ko) 1987-10-19
NO173635B (no) 1993-10-04
DK116687A (da) 1987-09-08
NZ219454A (en) 1989-04-26
NO173635C (no) 1994-01-12
HK63991A (en) 1991-08-23
ES2033247T3 (es) 1993-03-16
FI84977C (fi) 1992-02-25
IL81681A0 (en) 1987-09-16
SG45292G (en) 1992-06-12
IE870569L (en) 1987-09-07
NO870950L (no) 1987-09-08
ATE59290T1 (de) 1991-01-15
IE60025B1 (en) 1994-05-18
NO870950D0 (no) 1987-03-06
DK116687D0 (da) 1987-03-06
HU199286B (en) 1990-02-28
CA1283607C (en) 1991-04-30
AU593330B2 (en) 1990-02-08
HUT47020A (en) 1989-01-30
FI84977B (fi) 1991-11-15
PH22808A (en) 1988-12-27
AU6977387A (en) 1987-09-10
JPS62265220A (ja) 1987-11-18
FI870994A0 (fi) 1987-03-06
DK166754B1 (da) 1993-07-12
JPH0717500B2 (ja) 1995-03-01
EP0236822A2 (de) 1987-09-16
GR3001503T3 (en) 1992-11-23
PT84398A (en) 1987-04-01
ZA871652B (en) 1987-08-28
KR900002030B1 (ko) 1990-03-31
PT84398B (pt) 1989-10-04
IL81681A (en) 1991-01-31

Similar Documents

Publication Publication Date Title
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
ES2031876T3 (es) Un procedimiento para la preparacion de 5,6-dihidro-2-(fenil sustituido)-1,2,4,-triazin-3,5(2h,4h)-dionas.
DK529888D0 (da) Substituerede n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamider
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
SE8404065D0 (sv) Novel biologically active compounds
SE8600658D0 (sv) Novel composition of matter
DE3766984D1 (de) Stabile injizierbare arzneiformulierung des 1,4-dihydroxy-5,8-bis((2-(hydroxyaethylamino)-aethyl)amino)anthrachinondihydrochlorids.
ES2056955T3 (es) Formulacion oral de buspirona y sales de la misma.
PT86771A (pt) Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity
NO179072C (no) Glutarsyrederivater, samt fremstilling derav

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH HOLDINGS CORP., MADISON, N.J., US